Status:

COMPLETED

Respiratory Complications in ALS

Lead Sponsor:

Liverpool University Hospitals NHS Foundation Trust

Conditions:

Motor Neuron Disease

Pneumonia

Eligibility:

All Genders

18-99 years

Brief Summary

Respiratory failure is the leading cause of death in motor neuron disease (MND) patients. Symptoms of respiratory dysfunction in MND patients include sleep disturbance, excessive daytime somnolence, m...

Detailed Description

Respiratory failure is the leading cause of death in motor neuron disease (MND) patients. Symptoms of respiratory dysfunction in MND patients include sleep disturbance, excessive daytime somnolence, m...

Eligibility Criteria

Inclusion

  • Patients with ALS

Exclusion

  • None

Key Trial Info

Start Date :

June 1 2020

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

September 1 2021

Estimated Enrollment :

300 Patients enrolled

Trial Details

Trial ID

NCT04430686

Start Date

June 1 2020

End Date

September 1 2021

Last Update

September 22 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

LiverpoolUHNHS

Liverpool, United Kingdom